Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (‘CNS’) disorders, is delighted to announce the appointment of Paul Carter…
Astral Resources (AAR:AU) has announced Key Appointments to Advance Mandilla Gold Project Download the PDF here. This post appeared first on investingnews.com
Metals Focus published its annual Precious Metals Investment Focus report on Saturday (October 25). The report from the leading gold analysis firm outlines the investment options available for…